Myron Z. Holubiak, President and CEO at Citius Pharmaceuticals, Inc. (CTXR), bought 2,915 shares at $3.09 ($9K) on 2018-03-28, disclosed to the SEC on 2018-03-29.
Open-market purchase of $9k CTXR by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CTXR | BUY | 2018-08-15 | $2.0M | — | Filing → |
| BIOS | SELL | 2014-06-18 | $40K | — | Filing → |
| BIOS | SELL | 2013-07-23 | $510K | — | Filing → |